Amit Hazan
Stock Analyst at Goldman Sachs
(2.58)
# 2,540
Out of 4,829 analysts
95
Total ratings
75%
Success rate
6.82%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $156.44 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $6.74 | -62.91% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.76 | +979.55% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $13.50 | -40.74% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $45.23 | +39.29% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $175.34 | +55.13% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $11.89 | +42.98% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $16.29 | +2,570.35% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $54.44 | -19.18% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $74.80 | -2.41% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $31.88 | +66.25% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $36.57 | +55.87% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $12.67 | -25.02% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $131.99 | -21.21% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $9.49 | +532.24% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $85.81 | +34.02% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $388.08 | -61.35% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $102.87 | -55.28% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $561.43 | -56.95% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $98.22 | +80.21% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $154.14 | -4.63% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $1.66 | +134.94% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $156.44
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $6.74
Upside: -62.91%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.76
Upside: +979.55%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $13.50
Upside: -40.74%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $45.23
Upside: +39.29%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $175.34
Upside: +55.13%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $11.89
Upside: +42.98%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $16.29
Upside: +2,570.35%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $54.44
Upside: -19.18%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $74.80
Upside: -2.41%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $31.88
Upside: +66.25%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $36.57
Upside: +55.87%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $12.67
Upside: -25.02%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $131.99
Upside: -21.21%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $9.49
Upside: +532.24%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $85.81
Upside: +34.02%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $388.08
Upside: -61.35%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $102.87
Upside: -55.28%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $561.43
Upside: -56.95%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $98.22
Upside: +80.21%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $154.14
Upside: -4.63%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $1.66
Upside: +134.94%